What it's for (Indications)
- Fusidic acid with hydrocortisone is indicated for the treatment of inflammatory dermatoses, such as eczema or dermatitis, where bacterial infection is present or likely to occur.
- This combination therapy is particularly useful for conditions complicated by susceptible bacterial pathogens, predominantly Gram-positive organisms like *Staphylococcus aureus* and *Streptococcus spp.
- * The low-potency corticosteroid, hydrocortisone, effectively reduces inflammation, pruritus, and erythema, while fusidic acid provides targeted antibacterial action.
- This formulation is generally reserved for short-term use in localized, mild to moderate infected inflammatory skin conditions, helping to alleviate symptoms and eradicate the bacterial component efficiently.
- Its application should be guided by clinical assessment of both inflammation and infection.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | This topical preparation should be applied thinly and gently rubbed into the affected skin area two to three times daily, or as directed by a healthcare professional. The duration of treatment should be limited, typically not exceeding two weeks, to minimize the risk of developing corticosteroid-related side effects, such as skin atrophy, and to reduce the potential for antibiotic resistance development. If no improvement is observed within 7-14 days, or if the condition worsens, re-evaluation by a physician is necessary to consider alternative diagnoses or treatments. Hands should be washed thoroughly before and after applying the cream to prevent spread of infection and protect the user. Avoid use under occlusive dressings unless specifically advised by a doctor. |
Safety & Warnings
Common Side Effects
- The most commonly reported side effects are localized and generally mild, including irritation, burning, stinging, itching, erythema (redness), and dry skin at the application site.
- These reactions are often transient.
- Prolonged or extensive use, especially under occlusion or on sensitive skin areas (e.
- g.
- , face, intertriginous zones), may lead to corticosteroid-specific adverse effects such as skin atrophy, telangiectasia (spider veins), striae (stretch marks), hypertrichosis (excessive hair growth), acneiform eruptions, perioral dermatitis, and hypopigmentation.
- Systemic absorption, though rare with low-potency hydrocortisone, can occur with extensive application, leading to adrenal suppression, particularly in children.
- Allergic contact dermatitis to either active ingredient or excipients has also been reported.
Serious Warnings
- Black Box Warning: **Serious Warnings: Risk of Systemic Absorption and Masking of Infections** This combination topical product, containing a corticosteroid and an antibiotic, requires careful clinical consideration. While a formal FDA Black Box Warning has not been issued for topical fusidic acid/hydrocortisone, clinicians and patients must be aware of significant risks, particularly with prolonged, extensive, or inappropriate use. The corticosteroid component (hydrocortisone) carries the risk of systemic absorption, which can lead to reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria, especially in children or with occlusive dressings. Furthermore, the corticosteroid can mask the clinical signs of local infections, potentially allowing for the progression of underlying viral, fungal, or primary bacterial infections that are not susceptible to fusidic acid. Development of fusidic acid resistance can also occur with prolonged use, rendering future treatments ineffective. Therefore, treatment duration should be strictly limited to the shortest possible period, generally not exceeding two weeks.
- This product should be used with caution and for limited durations, typically not exceeding two weeks, to mitigate potential risks.
- Prolonged or extensive use, particularly in children or on sensitive areas such like the face, groin, or axillae, can lead to systemic absorption of hydrocortisone, increasing the risk of adrenal suppression, Cushing's syndrome, and other systemic corticosteroid effects.
- The presence of a corticosteroid can mask signs of infection, potentially allowing viral or fungal infections to progress.
- Care should be taken to avoid contact with the eyes, as prolonged ocular exposure to corticosteroids can lead to glaucoma and cataracts.
- Development of antibiotic resistance to fusidic acid is a concern with inappropriate or extended use.
- If irritation or sensitization occurs, treatment should be discontinued.
How it Works (Mechanism of Action)
Fusidic acid exerts its antibacterial effect by inhibiting bacterial protein synthesis. It specifically binds to elongation factor G (EF-G) and prevents its dissociation from the bacterial ribosome, thereby arresting the translocation step and ultimately leading to bacterial growth inhibition. It is primarily bacteriostatic but can be bactericidal at higher concentrations, with strong activity against *Staphylococcus aureus*, including some methicillin-resistant strains, and *Streptococcus spp.* Hydrocortisone, a low-potency topical corticosteroid, functions through its anti-inflammatory, antipruritic, and vasoconstrictive properties. It binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus to modulate gene expression, suppressing the release of inflammatory mediators (e.g., prostaglandins, leukotrienes) and downregulating immune responses, thereby reducing redness, swelling, and itching associated with inflammatory dermatoses.
Commercial Brands (Alternatives)
No other brands found for this formula.